Zevra Therapeutics, Inc. (ZVRA)
12.18
+0.12
(+1.00%)
USD |
NASDAQ |
Sep 02, 13:19
Zevra Therapeutics Net Income (TTM) : 56.00M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 56.00M |
| March 31, 2026 | 122.31M |
| December 31, 2025 | 82.89M |
| September 30, 2025 | 35.32M |
| June 30, 2025 | 2.644M |
| March 31, 2025 | -91.99M |
| December 31, 2024 | -105.51M |
| September 30, 2024 | -84.92M |
| June 30, 2024 | -62.07M |
| March 31, 2024 | -44.72M |
| December 31, 2023 | -41.31M |
| September 30, 2023 | -20.41M |
| June 30, 2023 | -16.66M |
| March 31, 2023 | -38.12M |
| December 31, 2022 | -26.77M |
| September 30, 2022 | -35.22M |
| June 30, 2022 | -30.37M |
| March 31, 2022 | -0.123M |
| December 31, 2021 | -8.555M |
| September 30, 2021 | -10.71M |
| June 30, 2021 | -11.96M |
| March 31, 2021 | -17.30M |
| Date | Value |
|---|---|
| December 31, 2020 | -12.76M |
| September 30, 2020 | -13.94M |
| June 30, 2020 | -7.869M |
| March 31, 2020 | -17.98M |
| December 31, 2019 | -24.52M |
| September 30, 2019 | -23.67M |
| June 30, 2019 | -41.80M |
| March 31, 2019 | -42.54M |
| December 31, 2018 | -56.47M |
| September 30, 2018 | -61.85M |
| June 30, 2018 | -56.76M |
| March 31, 2018 | -53.28M |
| December 31, 2017 | -43.39M |
| September 30, 2017 | -42.77M |
| June 30, 2017 | -46.20M |
| March 31, 2017 | -31.06M |
| December 31, 2016 | -17.67M |
| September 30, 2016 | -16.92M |
| June 30, 2016 | -13.25M |
| March 31, 2016 | -51.62M |
| December 31, 2015 | -54.66M |
| September 30, 2015 | -57.30M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Innoviva, Inc. | 357.24M |
| Collegium Pharmaceutical, Inc. | 47.92M |
| Johnson & Johnson | 21.04B |
| Ligand Pharmaceuticals, Inc. | 197.22M |
| Harrow, Inc. | -37.23M |